Metabolic Dysfunction-Associated Steatohepatitis Clinical Trials

3 recruiting

Frequently Asked Questions

Common questions about Metabolic Dysfunction-Associated Steatohepatitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting

The Development of MASLD Among Survivors of Breast or Colorectal Cancer

Breast Cancer SurvivorsColorectal (Colon or Rectal) Cancer SurvivorsMASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
University of Bern200 enrolled1 locationNCT07280143
Recruiting
Not Applicable

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

Insulin Sensitivity/ResistanceObesityInsulin Resistance+16 more
Pichamol Jirapinyo, MD, MPH132 enrolled2 locationsNCT06138821
Recruiting
Not Applicable

To Test Whether Time-restricted Eating Coupled With a Healthy Diet is Beneficial in Liver Cancer Patients

Obesity and OverweightLiver Cancer, AdultMASH - Metabolic Dysfunction-Associated Steatohepatitis
University of California, San Diego50 enrolled1 locationNCT06824974
Recruiting

Digital Early Warning System for Acute Lung Injury in Liver Surgery

MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Acute Lung Injury(ALI)Liver Cirrhosis+4 more
Beijing Tsinghua Chang Gung Hospital4,000 enrolled1 locationNCT07070362
Recruiting
Phase 2

Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis)

Metabolic Dysfunction-Associated SteatohepatitisChronic Kidney Disease Stage 3Chronic Kidney Disease Stage 2
Enyo Pharma60 enrolled1 locationNCT06939816
Recruiting

Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

Hepatocellular CarcinomaLiver TransplantMetabolic Dysfunction-Associated Steatotic Liver Disease+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna1,000 enrolled1 locationNCT06813508